Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq continued listing requirements, except as set out in Schedule 4.20. Except as set out in Schedule 4.20, there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Company’s Common Stock on the Nasdaq and the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as specified in Schedule 2.13, (i) the Company is in compliance with all applicable Nasdaq National Market continued listing requirements, except as set out in Schedule 4.20. Except as set out in Schedule 4.20, (ii) there are no proceedings pending or, or to the Company’s Knowledge, 's knowledge threatened against the Company relating to the continued listing of the Company’s Common Stock 's common stock on the Nasdaq National Market and (iii) the Company has not received any notice of, nor to the Company’s Knowledge knowledge of the Company is there any basis for, the delisting of the Common Stock such common stock from the NasdaqNasdaq National Market.
Appears in 1 contract
Samples: Stock Purchase Agreement (Syscomm International Corp)
Compliance with Nasdaq Continued Listing Requirements. The Except as described on Schedule 4.20, the Company is in compliance with applicable Nasdaq National Market continued listing requirements, except as set out in Schedule 4.20. Except as set out in described on Schedule 4.20, there are no proceedings pending or, to the Company’s 's Knowledge, threatened against the Company relating to the continued listing of the Company’s 's Common Stock on the Nasdaq National Market and the Company has not received any notice of, nor to the Company’s 's Knowledge is there any basis for, the delisting of the Common Stock from the NasdaqNasdaq National Market.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as set forth in Schedule 4.20, the Company is in compliance with applicable Nasdaq National Market continued listing requirements, except as set out in Schedule 4.20. Except as set out in Schedule 4.20, there There are no proceedings pending or, to the Company’s 's Knowledge, threatened against the Company relating to the continued listing of the Company’s 's Common Stock on the Nasdaq National Market and the Company has not received any notice of, nor to the Company’s 's Knowledge is there any basis for, the delisting of the Common Stock from the NasdaqNasdaq National Market.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as described on Schedule 3(t), the Company is in compliance with applicable Nasdaq National Market continued listing requirements, except as set out in Schedule 4.20. Except as set out in described on Schedule 4.203(t), there are no proceedings pending or, to the Company’s Knowledge's knowledge, threatened against the Company relating to the continued listing of the Company’s 's Common Stock on the Nasdaq National Market and the Company has not received any notice of, nor to the Company’s Knowledge 's knowledge is there any basis for, the delisting of the Common Stock from the NasdaqNasdaq National Market.
Appears in 1 contract
Samples: Secured Note Purchase Agreement (Alliance Pharmaceutical Corp)
Compliance with Nasdaq Continued Listing Requirements. The Except as described on Schedule 4.20, the Company is in compliance with applicable Nasdaq National Market continued listing requirements, except requirements as set out in Schedule 4.20currently enforced by the Nasdaq National Market. Except as set out in described on Schedule 4.20, there are no proceedings pending or, to the Company’s 's Knowledge, threatened against the Company relating to the continued listing of the Company’s 's Common Stock on the Nasdaq National Market and the Company has not received any notice of, nor to the Company’s 's Knowledge is there any basis for, the delisting of the Common Stock from the NasdaqNasdaq National Market.
Appears in 1 contract